The DOJ, HHS, FTC, and FDA coordinated efforts to restrict gender-affirming care through regulatory and enforcement actions. The multi-agency approach represents a systematic policy shift.
IF YOU ONLY DO ONE THING
Track agency rule-making dockets and litigation challenges to gender-affirming care restrictions for due process and equal protection violations.
Why This Score
Coordinated multi-agency regulatory action targeting narrow population; civil rights impact significant but scope narrow limits overall constitutional damage.